Quick-Med Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QMDT research report →
Price Chart
About the company
Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products.
- CEO
- Gerald Reisman
- IPO
- 2002
- Employees
- 5
- HQ
- Gainesville, FL, US
Get TickerSpark's AI analysis on QMDT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $18.67K
- P/E
- -0.03
- PEG
- -0.00
- P/S
- 0.02
- P/B
- -0.00
- EV/EBITDA
- -0.97
- Div Yield
- 0.00%
- Gross Margin
- 69.79%
- Op Margin
- -40.50%
- Net Margin
- -76.80%
- ROE
- 8.33%
- ROIC
- -974.59%
Latest fiscal year · YoY change
- Revenue
- $928.49K-6.9%
- Gross Profit
- $647.99K-3.5%
- Op Income
- $-376,075
- Net Income
- $-713,073+57.7%
- EPS
- $-0.02+57.7%
- OCF Growth
- +108.1%
- FCF Growth
- +99.9%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.81
- RSI (14)
- 0
- Avg Volume
- 65
No earnings-call transcripts are available for QMDT yet.
- Free Float
- 83.3%
- Shares Outstanding
- 37.35M
- Float Shares
- 31.10M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 7, 13 | PHRONESIS PARTNERS L P | sell | 10,100 |
| Feb 7, 13 | PHRONESIS PARTNERS L P | sell | 0 |
| Feb 7, 13 | PHRONESIS PARTNERS L P | sell | 25,000 |
| Feb 7, 13 | PHRONESIS PARTNERS L P | sell | 0 |
| Jan 30, 13 | PHRONESIS PARTNERS L P | sell | 0 |
| Jan 30, 13 | PHRONESIS PARTNERS L P | sell | 9,900 |
| Jan 11, 13 | PHRONESIS PARTNERS L P | sell | 10,000 |
| Jan 11, 13 | PHRONESIS PARTNERS L P | sell | 0 |
| Jan 8, 13 | PHRONESIS PARTNERS L P | sell | 3,000 |
| Jan 8, 13 | PHRONESIS PARTNERS L P | sell | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our QMDT coverage
Recent articles, reports, and earnings notes.
No research on QMDT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate QMDT report →